CSIMarket
 


Abeona Therapeutics Inc   (ABEO)
Other Ticker:  
 
 

ABEO's Gross Income Growth by Quarter and Year

Abeona Therapeutics Inc 's Gross Income results by quarter and year




ABEO Gross Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.43 3.00 3.00
III Quarter September 0.59 0.07 0.00 7.00
II Quarter June 3.92 1.00 0.00 0.00
I Quarter March 0.36 0.35 0.00 0.00
FY   4.87 1.85 3.00 10.00



ABEO Gross Income third quarter 2023 Y/Y Growth Comment
Abeona Therapeutics Inc achieved in the third quarter 2023, above Company average Gross Income surge of 747.14% year on year, to $ 0.59 millions.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 177 other companies have achieved higher Gross Income growth. While Abeona Therapeutics Inc ' s Gross Income doubling of 747.14% ranks overall at the positon no. 3369 in the third quarter 2023.

Explain Gross Income Margin


ABEO Gross Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -85.67 % 0 % -
III Quarter September 747.14 % - - -
II Quarter June 292 % - - -
I Quarter March 2.86 % - - -
FY   - -38.33 % -70 % -

Financial Statements
Abeona Therapeutics Inc 's third quarter 2023 Gross Income $ 0.59 millions ABEO's Income Statement
Abeona Therapeutics Inc 's third quarter 2022 Gross Income $ 0.07 millions Quarterly ABEO's Income Statement
New: More ABEO's historic Gross Income Growth >>


ABEO Gross Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 514.29 % - -57.14 %
III Quarter September -84.87 % -93 % - -
II Quarter June 988.89 % 185.71 % - -
I Quarter March -16.28 % -88.33 % - -
FY (Year on Year)   - -38.33 % -70 % -




Gross Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #178
Healthcare Sector #487
Overall #3369

Gross Income Y/Y Growth Statistics
High Average Low
508.31 % 50.29 % -78.78 %
(Sep 30 2018)   (June 30. 2014)
Gross Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #178
Healthcare Sector #487
Overall #3369
Gross Income Y/Y Growth Statistics
High Average Low
508.31 % 50.29 % -78.78 %
(Sep 30 2018)   (June 30. 2014)

Gross Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Abeona Therapeutics Inc 's Q/Q Gross Income Growth


Gross Income Q/Q Growth Statistics
High Average Low
976.1 % 32.55 % -100 %
(Jun 30 2023)  


ABEO's III. Quarter Q/Q Gross Income Comment
In the III. Quarter 2023 Abeona Therapeutics Inc reported fall in Gross Income sequentially by -84.87% to $ 0.59 millions, from $ 3.92 millions released a quarter before.

This is not huge issue, as Gross Income frequently tend to dip in the III. Quarter.

Within Major Pharmaceutical Preparations industry 235 other companies have achieved higher Gross Income quarter on quarter growth. While Abeona Therapeutics Inc 's Gross Income growth quarter on quarter, overall rank is 3781.


Gross Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #236
Healthcare Sector #613
Overall #3781
Gross Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #236
Healthcare Sector #613
Overall #3781
Gross Income Q/Q Growth Statistics
High Average Low
976.1 % 32.55 % -100 %
(Jun 30 2023)  


ABEO's III. Quarter Q/Q Gross Income Comment
In the III. Quarter 2023 Abeona Therapeutics Inc realized fall in Gross Income sequentially by -84.87% to $ 0.59 millions, from $ 3.92 millions declared in the previous quarter.

This is not important problem, as Gross Income generally gravitate to plunge in the III. Quarter.

Within Major Pharmaceutical Preparations industry 235 other companies have achieved higher Gross Income quarter on quarter growth. While Abeona Therapeutics Inc 's Gross Income growth quarter on quarter, overall rank is 3781.


Abeona Therapeutics Inc 's 12 Months Gross Income Growth Year on Year


Gross Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Gross Income 12 Months Ending $ 5.30 $ 4.78 $ 1.86 $ 1.85 $ 4.42
Y / Y Gross Income Growth (TTM) 19.99 % - - - -
Year on Year Gross Income Growth Overall Ranking # 1140 # 0 # 0 # 0 # 0
Seqeuential Gross Income Change (TTM) 10.9 % 156.58 % 0.98 % -58.24 % -
Seq. Gross Income Growth (TTM) Overall Ranking # 3369 # 2998 # 3644 # 0 # 0




Cumulative Gross Income growth Comment
Although Abeona Therapeutics Inc 's Annual Gross Income growth year on year were below company's average 50.29% , Gross Income announced in the Sep 30 2023 period, show improvement in Gross Income trend, to cumulative trailing twelve month growth of 19.99% year on year, from % in Jun 30 2023.

In the Healthcare sector 207 other companies have achieved higher trailing twelve month Gross Income growth. While Gross Income growth total ranking has deteriorated compare to previous quarter from 0 to 1140.

Gross Income TTM Q/Q Growth Statistics
High Average Low
508.31 %
50.29 %
-78.78 %
 

Gross Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 178
Healthcare Sector # 208
Overall # 1140

Gross Income TTM Y/Y Growth Statistics
High Average Low
508.31 %
50.29 %
-78.78 %
 


Gross Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 178
Sector # 487
S&P 500 # 3369
Cumulative Gross Income growth Comment
Although Abeona Therapeutics Inc 's Annual Gross Income growth year on year were below company's average 50.29% , Gross Income announced in the Sep 30 2023 period, show improvement in Gross Income trend, to cumulative trailing twelve month growth of 19.99% year on year, from % in Jun 30 2023.

In the Healthcare sector 207 other companies have achieved higher trailing twelve month Gross Income growth. While Gross Income growth total ranking has deteriorated compare to previous quarter from 0 to 1140.

Gross Income TTM Q/Q Growth Statistics
High Average Low
508.31 %
50.29 %
-78.78 %
 


Gross Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 178
Healthcare Sector # 208
Overall # 1140

Gross Income TTM Y/Y Growth Statistics
High Average Low
508.31 %
50.29 %
-78.78 %
 


Gross Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 178
Sector # 487
S&P 500 # 3369




Other Gross Income Growth
Major Pharmaceutical Preparations Industry Gross Income Growth Trends and Statistics
Healthcare Sector Gross Income Growth Statistics
Gross Income Growth Trends for overall market
ABEO's Gross Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Income Growth
Lowest Ranking Gross Income Growth
Gross Income Growth for ABEO's Competitors
Gross Income Growth for Abeona Therapeutics Inc 's Suppliers
Gross Income Growth for ABEO's Customers

You may also want to know
ABEO's Annual Growth Rates ABEO's Profitability Ratios ABEO's Asset Turnover Ratio ABEO's Dividend Growth
ABEO's Roe ABEO's Valuation Ratios ABEO's Financial Strength Ratios ABEO's Dividend Payout Ratio
ABEO's Roa ABEO's Inventory Turnover Ratio ABEO's Growth Rates ABEO's Dividend Comparisons



Companies with similar Gross Income fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Gross Income for the quarter ending Sep 30 2023
Spero Therapeutics Inc 1,169.84%$ 1,169.840 millions
Seelos Therapeutics inc 1,127.78%$ 1,127.778 millions
Fusion Pharmaceuticals Inc 1,108.43%$ 1,108.434 millions
Ardelyx Inc 1,044.78%$ 1,044.781 millions
Inhibikase Therapeutics Inc 991.33%$ 991.332 millions
Bridgebio Pharma Inc 933.43%$ 933.432 millions
Lucid Diagnostics Inc 930.26%$ 930.263 millions
Ovid Therapeutics Inc 881.55%$ 881.553 millions
Mallinckrodt Plc872.90%$ 872.903 millions
Lyell Immunopharma Inc 733.33%$ 733.333 millions
Abeona Therapeutics Inc 723.61%$ 723.611 millions
Malachite Innovations Inc 698.74%$ 698.743 millions
Invo Bioscience Inc 672.47%$ 672.469 millions
Mei Pharma Inc 647.96%$ 647.961 millions
Immunogen inc 637.72%$ 637.724 millions
Axim Biotechnologies Inc 629.15%$ 629.148 millions
Caribou Biosciences Inc 616.38%$ 616.379 millions
Clever Leaves Holdings Inc 593.57%$ 593.571 millions
Zymeworks Inc 527.37%$ 527.366 millions
Nuo Therapeutics Inc 461.87%$ 461.874 millions
Lftd Partners Inc 443.41%$ 443.415 millions
Rhythm Pharmaceuticals inc 430.55%$ 430.552 millions
Volitionrx Limited405.02%$ 405.016 millions
Apellis Pharmaceuticals Inc 400.54%$ 400.540 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com